Disease Progression in Children With Friedreich Ataxia: Functional Performance and Other Outcome Assessments in the FACHILD Study. [PDF]
Rummey C +5 more
europepmc +1 more source
Increase of Plasma Biomarkers in Friedreich's Ataxia: Potential Insights into Disease Pathology. [PDF]
Rummey C +9 more
europepmc +1 more source
Therapeutic combination of L-ascorbic acid, N-acetylcysteine, and dimethyl fumarate in Friedreich's ataxia: insights from in vitro models. [PDF]
Edzeamey FJ +6 more
europepmc +1 more source
Clinical and cognitive assessment in Friedreich ataxia clinical trials: a review. [PDF]
Darriba Á +4 more
europepmc +1 more source
Molecular mechanisms of iron metabolism and ferroptosis in cardiovascular diseases and intervention strategies targeting natural products (Review). [PDF]
Ge L +5 more
europepmc +1 more source
Antisense oligonucleotide therapy for patients with Friedreich's ataxia carrying the c.165+5G>C splicing mutation. [PDF]
Yameogo P +6 more
europepmc +1 more source
Predictive machine learning and multimodal data to develop highly sensitive, composite biomarkers of disease progression in Friedreich ataxia. [PDF]
Saha S +4 more
europepmc +1 more source
Base editing as a therapeutic strategy for somatic repeat expansion diseases. [PDF]
Saha K.
europepmc +1 more source
Redox homeostasis and inflammation in fibroblasts of patients with Friedreich Ataxia: a possible cross talk. [PDF]
Quatrana A +5 more
europepmc +1 more source
Long-Read Sequencing Identifies Mosaic Sequence Variations in Friedreich's Ataxia-GAA Repeats. [PDF]
Park J +11 more
europepmc +1 more source

